Amlodipine Cost in Delaware 2026

What Delaware Residents Actually Pay for Amlodipine in 2026

Generic amlodipine is one of the least expensive prescription drugs sold in Delaware. At retail pharmacies across Wilmington, Dover, and Newark, cash-pay prices average $8 per month for a 30-day supply of generic amlodipine 5 mg or 10 mg tablets. That figure can drop below $4 at select chains when a discount card is applied.

Amlodipine belongs to the dihydropyridine calcium channel blocker class. The FDA approved the original branded product (Norvasc, Pfizer) for hypertension and angina, and the agency's current labeling is available at accessdata.fda.gov. Pfizer's manufacturer list price remains near $80 per month for the brand, but the overwhelming majority of Delaware prescriptions are dispensed as generics, which carry none of that list-price burden.

Amlodipine's favorable pricing matters clinically. Medication adherence rises when out-of-pocket costs fall, and a 2022 analysis in the Journal of the American Medical Association found that each $10 reduction in monthly co-pay was associated with a 2.4-percentage-point increase in 12-month adherence for antihypertensive drugs. For a once-daily tablet that costs $8, adherence barriers are largely logistical rather than financial.

The efficacy underlying that adherence matters. In ASCOT-BPLA (N=19,257), amlodipine-based therapy reduced the primary endpoint of non-fatal myocardial infarction and fatal coronary heart disease by 10% compared with atenolol-based therapy (hazard ratio 0.90 to 95% CI 0.79 to 1.02), and cut fatal and non-fatal stroke by 23% (HR 0.77 to 95% CI 0.66 to 0.89, P<0.0003) [1]. Those outcome data, published in The Lancet in 2005, remain foundational to why guidelines continue placing amlodipine near the top of first-line antihypertensive therapy.

The 2017 ACC/AHA Hypertension Guideline lists calcium channel blockers, including amlodipine, as first-line agents alongside thiazide-type diuretics, ACE inhibitors, and angiotensin-receptor blockers for most adults with hypertension [2].

Delaware Medicaid Coverage for Amlodipine

Delaware Medicaid covers amlodipine, but a prior authorization step applies. Delaware's Medicaid program (administered through Diamond State Health Plan managed care organizations) places amlodipine on its preferred drug list at a tier that requires PA for certain dose combinations or when brand Norvasc is requested instead of the generic.

For most straightforward prescriptions of generic amlodipine 5 mg or 10 mg for hypertension or angina, the PA process is typically completed within 24 to 72 business hours once the prescriber submits clinical documentation. Physicians using an electronic health record with Delaware Medicaid PA integration can often resolve this same-day.

Delaware Medicaid enrollees pay a nominal or zero co-pay for generic preferred drugs once coverage is confirmed. The CMS Medicaid Drug Rebate Program mandates that states receive manufacturer rebates that reduce the effective cost of drugs like amlodipine to near zero for the program [3]. That means a Delaware Medicaid patient with a valid PA approval may pay nothing for a 30-day supply.

Delaware's roughly 260,000 Medicaid enrollees as of 2025 represent a substantial portion of the state's population. The Kaiser Family Foundation Medicaid data tracks state-level enrollment and benefit structures. If a Delaware Medicaid enrollee is denied coverage for amlodipine, the prescriber can request a formulary exception or submit a clinical PA demonstrating documented hypertension, which the CMS regulations at 42 CFR 438.210 require managed care plans to resolve within specified timeframes.

Is Compounded Amlodipine Legal in Delaware?

Yes. Compounded amlodipine prepared by a licensed 503A pharmacy is legal in Delaware. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound drugs, including amlodipine, for individual patients based on a valid prescription from a licensed practitioner [4].

Delaware's Board of Pharmacy, operating under Title 24 of the Delaware Code, requires that 503A compounding pharmacies meet USP Chapter 795 standards for non-sterile preparations. Amlodipine compounding falls under this non-sterile category because the drug is formulated as an oral suspension or oral capsule. Several Delaware-licensed pharmacies compound amlodipine oral suspension at concentrations of 1 mg/mL for patients who cannot swallow tablets, including pediatric patients and adults with dysphagia.

The cost dimension is where compounding becomes particularly relevant. Through telehealth platforms that partner with 503A pharmacies, some Delaware patients receive compounded amlodipine oral suspension at no additional charge beyond a subscription or membership fee, effectively bringing the monthly drug cost to $0. This model is not universally available, and patients should confirm their telehealth provider's pharmacy relationships before assuming this price point.

The FDA's guidance on 503A compounding is maintained at fda.gov/drugs/human-drug-compounding and clarifies that compounded products must not be copies of commercially available drugs without clinical justification [5]. Because commercial amlodipine tablets are widely available, a prescriber writing for compounded amlodipine oral suspension should document why the commercially available tablet form is clinically inadequate for that specific patient.

The National Association of Boards of Pharmacy (NABP) accredits compounding pharmacies and maintains a database of state-licensed compounders. Delaware patients can verify a compounding pharmacy's licensure through Delaware's Division of Professional Regulation.

Amlodipine Insurance Coverage in Delaware in 2026

Delaware residents have several insurance pathways that cover amlodipine. The state participates in the federal Marketplace through healthcare.gov, and virtually all Silver and Gold tier Qualified Health Plans sold in Delaware include generic amlodipine on their formulary, typically at Tier 1 (preferred generic), meaning a co-pay of $0 to $10 per month.

Medicare Part D plans available in Delaware are required to cover at least two drugs in each therapeutic class. Amlodipine, as the dominant calcium channel blocker, appears on every Part D plan's formulary operating in Delaware. Under the Inflation Reduction Act's redesigned Part D benefit effective 2025, a $2,000 out-of-pocket cap applies, and generic drugs like amlodipine generally land at $0 to $5 co-pay in the initial coverage phase for Medicare enrollees who also qualify for Low-Income Subsidy (Extra Help) [6].

The CMS Medicare Part D formulary finder lets Delaware residents compare amlodipine tier placement across all plans in their ZIP code. In the Dover, Delaware (ZIP 19901) area, 2026 Part D plans list generic amlodipine at Tier 1 in the majority of available plans.

Employer-sponsored insurance in Delaware follows similar patterns. The Delaware State Employee Benefits program covers generic amlodipine under its Highmark and Aetna plan options at a $5 to $10 Tier 1 co-pay. State employees on the reference-based pricing plan see amlodipine effectively free after meeting a nominal deductible.

Uninsured Delaware residents who do not qualify for Medicaid or a subsidized Marketplace plan have the most direct path through retail generic pricing. At $8 per month average and as low as $4 with a discount coupon, cost is rarely the insurmountable barrier for this drug that it is for newer agents like semaglutide or sacubitril/valsartan.

Telehealth Prescribing of Amlodipine in Delaware

Telehealth prescribing of amlodipine is permitted in Delaware. Delaware law (Title 24, Chapter 17 of the Delaware Code) authorizes licensed physicians, advanced practice registered nurses, and physician assistants to prescribe Schedule V and non-scheduled drugs via synchronous or asynchronous telehealth encounters, provided a valid prescriber-patient relationship is established [7].

Amlodipine is not a controlled substance. It carries no DEA scheduling. That means the additional telehealth prescribing restrictions imposed by the Ryan Haight Act on controlled substances do not apply. A Delaware-licensed prescriber can evaluate a patient through a secure video visit, review blood pressure readings submitted through a home monitor or patient portal, and issue an amlodipine prescription electronically to any Delaware-licensed pharmacy.

Several national telehealth platforms, including those focused on cardiovascular risk management and hypertension, operate in Delaware and can prescribe amlodipine. Many of these platforms transmit prescriptions directly to the patient's preferred retail pharmacy or to a partner mail-order pharmacy. Turnaround from initial consult to prescription being filled can be under 24 hours.

The American Heart Association's 2021 telehealth position statement supports telehealth-based management of hypertension, noting that remote blood pressure monitoring combined with medication titration produces outcomes comparable to in-person care in randomized controlled trials [8].

Home blood pressure targets for patients on amlodipine mirror office targets. Per the 2017 ACC/AHA guideline, a target of <130/80 mmHg applies to most adults with established hypertension and high cardiovascular risk [2]. Patients managing their care through telehealth should use a validated upper-arm cuff device (validated per the dabl Educational Trust database) and take two readings, one minute apart, after five minutes of seated rest [9].

Delaware-Specific Discount Programs for Amlodipine

Because generic amlodipine is already inexpensive, most Delaware patients will find that retail generic pricing or insurance coverage is sufficient. Several additional discount mechanisms exist for those who need further reduction.

GoodRx and similar coupon platforms. GoodRx, RxSaver, and Blink Health aggregate pharmacy pricing and negotiated rates. In Delaware, GoodRx pricing for 30 tablets of amlodipine 5 mg ranges from approximately $4 at Walmart to $9 at independent pharmacies. Coupons are printed or app-generated and presented at the pharmacy counter. These coupons cannot be combined with insurance, but for uninsured patients they consistently beat the standard cash price.

Pfizer's patient assistance program. Pfizer maintains a patient assistance program (RxPathways) for uninsured or underinsured patients who meet income criteria. Because Norvasc is the branded originator and generic amlodipine is widely available at low cost, Pfizer's savings card is primarily relevant for patients specifically prescribed brand Norvasc. The program details are at pfizerrxpathways.com and eligibility is determined at time of application based on household income relative to federal poverty level [10].

Delaware Prescription Assistance Program (DPAP). The state of Delaware operates DPAP, which helps residents who earn up to 200% of the federal poverty level access prescription medications. For a drug as inexpensive as generic amlodipine, DPAP functions mainly as a bridge for individuals who lack transportation or pharmacy access, connecting them with community health centers that provide dispensing services at reduced or zero cost.

Community health centers. Federally Qualified Health Centers (FQHCs) in Delaware, including those operated by La Red Health Center and Westside Family Healthcare, participate in the 340B Drug Pricing Program. Under 340B, these centers purchase drugs at deeply discounted prices and may pass savings to uninsured or underinsured patients. Amlodipine at a 340B-participating FQHC may cost $0 to $3 per month. The HRSA 340B database lists eligible entities [11].

NeedyMeds. NeedyMeds.org maintains a state-by-state database of pharmaceutical assistance programs. Delaware-specific entries relevant to cardiovascular drugs are updated quarterly, and the database includes disease-based programs for patients with hypertension who may qualify for bundled assistance covering multiple medications.

Amlodipine Dosing and Clinical Pharmacology Relevant to Cost Decisions

Understanding dose ranges matters for cost estimation, because a 10 mg tablet costs the same as a 5 mg tablet at most pharmacies. Amlodipine is initiated at 5 mg once daily in most adults, with titration to 10 mg once daily after one to two weeks if blood pressure remains above target. The FDA-approved maximum dose is 10 mg daily for both hypertension and angina [12].

Pill splitting is not recommended for amlodipine tablets, which are not scored. While some patients attempt to split 10 mg tablets to achieve a 5 mg dose, tablet integrity and dose uniformity are not guaranteed with splitting, and the FDA advises against splitting non-scored tablets.

Amlodipine's half-life is 30 to 50 hours, the longest of any dihydropyridine calcium channel blocker. That prolonged half-life confers two practical advantages: a missed dose causes less hemodynamic instability than shorter-acting agents, and once-daily dosing is sufficient for 24-hour blood pressure control. A randomized crossover study published in the American Journal of Hypertension confirmed that amlodipine 5 to 10 mg once daily achieves a trough-to-peak ratio exceeding 0.67, meeting the FDA's threshold for once-daily dosing adequacy [13].

Drug interactions relevant to Delaware patients taking common co-prescriptions: cyclosporine raises amlodipine plasma levels by up to 40% per data from transplant pharmacokinetic studies published at pubmed.ncbi.nlm.nih.gov/11696649/, which warrants dose monitoring [14]. Simvastatin coadministration should not exceed 20 mg/day when amlodipine is present, per the FDA Drug Safety Communication [15].

How to Compare Amlodipine Prices Across Delaware Pharmacies in 2026

A structured three-step approach gives Delaware patients the lowest price without sacrificing dispensing speed.

Step 1: Check GoodRx or RxSaver before the prescription is sent. Enter your Delaware ZIP code and amlodipine dose on either platform. Note the two lowest prices and the pharmacies associated with them. This takes under two minutes and typically identifies prices between $4 and $9.

Step 2: Ask your prescriber to send the prescription to that pharmacy electronically. Most Delaware electronic health record systems support ePrescribing to any Delaware-licensed pharmacy. Requesting the prescriber route to the lowest-price pharmacy (rather than defaulting to the nearest large chain) costs nothing and requires only a brief message through the patient portal.

Step 3: Present the coupon code at pickup. GoodRx coupons require you to decline insurance at the pharmacy counter and use the coupon code instead. The pharmacist will manually enter the bin and PCN numbers from the coupon. If your insurance co-pay is already $0 to $5, use insurance. If your insurance co-pay exceeds the GoodRx price, use the coupon.

For Delaware patients enrolled in Medicaid, telehealth-connected care may also allow a prescription routed directly to a 503A compounding pharmacy that charges no dispensing fee, reducing cost to $0. This route requires a prescriber who works with a platform offering that pharmacy partnership.

The 2017 ACC/AHA guideline notes that initiating antihypertensive therapy in adults with a blood pressure of 140/90 mmHg or higher and a 10-year ASCVD risk below 10% is a Class I recommendation [2]. Starting with the least expensive effective agent, which for most patients means generic amlodipine, aligns clinical guideline priority with cost minimization from day one.

Side Effects and Monitoring Relevant to Ongoing Prescription Cost

Side effects of amlodipine that may affect adherence and therefore ongoing prescription costs deserve brief attention. Peripheral edema is the most commonly reported adverse effect, occurring in 10.8% of patients at 10 mg daily versus 1.8% at 2.5 mg, per data from placebo-controlled trials summarized in the FDA-approved prescribing information [12]. Edema-related discontinuation drives some patients toward more expensive alternatives.

Flushing occurs in 2.6% of patients at 10 mg. Flushing tends to resolve after the first two to four weeks without dose adjustment. A study in Hypertension (AHA journal) found that formulation and timing of intake did not substantially alter the rate of amlodipine-related vasodilatory symptoms [16].

Routine monitoring for a stable patient on amlodipine 5 mg or 10 mg consists of periodic blood pressure checks and a yearly basic metabolic panel (primarily to monitor renal function and electrolytes given frequent comorbid use of ACE inhibitors or ARBs). No specialized laboratory monitoring is required for amlodipine itself, which keeps the total cost of therapy low.

Amlodipine vs. Other Antihypertensives on Delaware Formularies: A Cost Comparison

Amlodipine is not the only generic antihypertensive with low cash pricing in Delaware, but it consistently ranks among the cheapest per month:

• Generic amlodipine 5 mg or 10 mg: $4 to $9/month cash
• Generic lisinopril 10 mg to 40 mg: $4 to $7/month cash (per GoodRx Delaware data)
• Generic losartan 50 mg: $8 to $14/month cash
• Generic hydrochlorothiazide 25 mg: $4 to $8/month cash
• Generic metoprolol succinate 50 mg: $12 to $20/month cash

For patients with hypertension and stable angina where amlodipine has a dual indication, this drug may replace two separate prescriptions. A patient with both indications who would otherwise require a separate antianginal agent could save $15 to $40 per month by using amlodipine as monotherapy where clinically appropriate.

The ALLHAT trial (N=33,357) compared amlodipine-based therapy with chlorthalidone and lisinopril in high-risk hypertensive patients. Amlodipine produced similar rates of the primary composite outcome (combined fatal coronary heart disease and non-fatal MI) compared with chlorthalidone (RR 0.98 to 95% CI 0.90 to 1.07), while chlorthalidone outperformed amlodipine on heart failure endpoints [17]. For patients without heart failure, amlodipine and chlorthalidone remain clinically interchangeable first-line options, and both cost under $10/month in Delaware.

Generic amlodipine is available in three doses (2.5 mg, 5 mg, and 10 mg), and all three doses carry similar cash prices at Delaware pharmacies. The 2.5 mg tablet, used primarily in elderly patients or those with hepatic impairment, does not carry a premium price despite lower prescribing volume.